The RSV diagnostics market is experiencing significant growth as global healthcare systems continue to prioritize early and accurate detection of respiratory syncytial virus (RSV) infections, especially among infants, immunocompromised individuals, and the elderly. According to Expert Market Research, the global RSV diagnostics market reached a value of USD 1028.55 million in 2024 and is...